Just working through this on the fly, so bear with me...(no, not you specifically bear, but you are included).  

April 28th trading in Hepa is halted pending news of an acquisition....check.

April 28 was a Friday....the following Monday Resverlogix presented at Bloom Burton in Toronto, here's the PPP:

http://www.resverlogix.com/upload/media_element/274/01/rvx---bloom-burton-2017.pdf

Agenda item #5 was Financial Position & Opportunities....check.  But then if you scroll through the presentation it looks like any slides associated with Item #5 were maybe removed.  Could it be that they were in fact deleted from the presentation? But someone forgot to update the page with the Agenda?  I emailed Sarah about it, asking if it was incompetence, and she said that item #5 was briefly addressed orally in the presentation.  

Hmmmmmm

This wasn't a scientific conference, to sell the scientific community on the company and Apabetalone....this was an Investor Conference, the intention of which is to drive investor interest.

Then we just had the Bio-Invest Europe conference in Paris...another investor conference.  And the company doesn't even show up and doesn't even bother putting out notice to shareholders that they won't be attending.  

Now we have news coming out regularily....but nothing about how they're going to be paying for any of these new developments like the phase 2a CKD trial....to say nothing of funding the completion of BETonMACE.

If Resverlogix does get acquired I'm good with it....if the science bears out (sorry again bear) then there are people who really need this compound.  My neighbour is on dialysis and just got back from a bypass operation because of a blocked artery or arteries...85% blockage or something like that.  

From a purely selfish perspective I'd love for any deal to involve a company of Pfizer's stature....but whatever.  

According to the profile on WSJ Hepa has over $4 billion in cash and equivilants, which I assume to be in US dollars:

http://quotes.wsj.com/CN/XSHE/002399/financials

Is this speculation out to lunch?  Or does anyone think that the timing around recent events with the halt in Hepa's trading and the Bloom Burton mess and the canceled Paris investor conference....does anyone think there could be a connection?  

And if you think I'm just relieving myself into the wind (again) no worries pointing that out either.